A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.
Demirkol S, Gomceli I, Isbilen M, Dayanc BE, Tez M, Bostanci EB, Turhan N, Akoglu M, Ozyerli E, Durdu S, Konu O, Nissan A, Gonen M, Gure AO.
Demirkol S, et al. Among authors: bostanci eb.
J Cancer. 2017 Apr 9;8(7):1113-1122. doi: 10.7150/jca.17872. eCollection 2017.
J Cancer. 2017.
PMID: 28607584
Free PMC article.